Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLN compared with ADCT: revenue, margins and what each company keeps, and the suppliers and customers both name
SLN
Silence Therapeutics plc
Change
Mkt cap
Revenue
Revenue
ADCT
ADC Therapeutics SA
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLN
Silence Therapeutics plc
vs
ADCT
ADC Therapeutics SA
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
SLN
No earnings history for SLN.
ADCT
0 of 3
at or beyond implied
Report
implied
realized
× implied
Oct 13 '26
—
▼
−8.60%
—
Q2 FY26
±90.3%
▼
−14.63%
×0.16
May 4 '26
±23.0%
▼
−3.92%
×0.17
Q1 FY26
±38.8%
▲
+13.48%
×0.35
= implied
SLN realized, solid
ADCT realized, hatched
One scale, both sides: full bar = 91%
× = |realized| ÷ implied
Source: market data
SLN
Silence Therapeutics plc
Change
19.77
▲
+0.10%
· post 19.76
Mkt cap
$933.1M
Revenue
$422,000
Q1 FY26
Revenue
$559,000
FY25
ADCT
ADC Therapeutics SA
Change
1.55
▲
+1.31%
· post 1.55
Closed
Nov 2 '26
Mkt cap
$196.6M
Revenue
$19M
Q2 FY26
Revenue
$71M
FY24
vs
Compare
Closed
Nov 2 '26
SLN
Silence Therapeutics plc
vs
ADCT
ADC Therapeutics SA
19.77
▲
+0.10%
post 19.76
Price
1.55
▲
+1.31%
post 1.55
$933.1M
Mkt cap
$196.6M
Q1 FY26
$422,000
Revenue
$19M
Q2 FY26
FY25
$559,000
Revenue
$71M
FY24
Change
Change
SLN
19.77
▲
+0.10%
vs
ADCT
1.55
▲
+1.31%
Closed
Nov 2 '26